Google Scholar | Citations: 16429| h-index: 32 | i10-index: 482
Epidemiological aspects of spotted fever in Brazil
PDF (Portuguese (Brazil))

Keywords

Spotted fever
Rickettsia rickettsii
Surveillance des zoonoses
Epidemiology

How to Cite

Epidemiological aspects of spotted fever in Brazil. (2025). Electronic Journal Collection Health, 25(8), e21122. https://doi.org/10.25248/reas.e21122.2025

Copyright © | All rights reserved.

The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.

Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.

Total reproduction
It is expressly prohibited and must be authorized by the journal.

Abstract

Objective: To describe the epidemiological panorama of spotted fever in Brazil from 2018 to 2023. Methods: This is a descriptive, retrospective, and longitudinal study with data from the Notifiable Diseases Information System and the Health and Environmental Surveillance Secretariat. The study variables were confirmed cases by region of the country, education, sex, ethnicity, age group, and deaths. The data were stored in electronic spreadsheets and analyzed using descriptive statistics. Results: The southeast region had the highest number of cases, with a significant increase in 2023. Men aged 40 to 59 were the most affected, with a higher proportion of cases of the disease in individuals with low education. In seasonal terms, the spring months had the highest peaks in cases. Mortality remains high, especially in regions with limited access to health services. Conclusion: Spotted fever continues to be a significant public health threat in Brazil, especially in the southeast, where higher population density, favorable ecological conditions and contact with vectors facilitate its spread. Regional and sociodemographic disparities indicate the need for more effective prevention and treatment strategies.

PDF (Portuguese (Brazil))

References

ARGENTINO Í, et al. Perfil epidemiológico dos casos notificados de febre maculosa nos anos de 2018 a 2022. Revista Contemporânea, 2024; 4(6): e4519.

BRAGAGNOLLO G, et al. Desenvolvimento e validação de tecnologia educacional interativa sobre febre maculosa. Revista Latino-Americana de Enfermagem, 2020; 28: e3375.

BRASIL. Boletim Epidemiológico do Ministério da Saúde. 2024. Disponível em: https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/boletins/epidemiologicos/edicoes/2024/boletim-epidemiologico-volume-55-no-09.pdf#:~:text=Durante%20o%20período%20analisado%20ocorreram,19%2C3%25%20em%202023.Acessado em: 6 de setembro de 2024.

BRASIL. Conselho Nacional de Saúde. Resolução nº 510, de 7 de abril de 2016. Brasília, DF: Ministério da Saúde, 2016.

BRASIL. Lei Geral de Proteção de Dados Pessoais (LGPD). Brasília, DF: Presidência da República, (2020). Acessado em: 23 de março de 2025.

BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde e Ambiente. Febre maculosa. 2024. Disponível em: http://www.gov.br/saude/febre-maculosa. Acessado em: 6 de setembro de 2024.

BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde. Óbitos por febre maculosa: Brasil, grandes regiões e unidades federadas, 2007-2024. 2024. Disponível em: https://www.gov.br/saude/pt-br/assuntos/saude-de-a-a-z/f/febre-maculosa/situacao-epidemiologica/obitos-de-febre-maculosa-brasil-grandes-regioes-e-unidades-federadas-infeccao-2007-a-2024/view. Acessado em: 7 de setembro de 2024.

BRETT M, et al. U.S. Healthcare providers’ experience with Lyme and other tick-borne diseases. Ticks and Tick-Borne Diseases, 2014; 5(4): 404-408.

DANTAS-TORRES F. Rocky Mountain spotted fever. The Lancet Infectious Diseases, 2007; 7(11): 724–732.

DE ARAUJO R, et al. Febre maculosa no Brasil: estudo da mortalidade para a vigilância epidemiológica. Caderno de Saúde Coletiva, 2015; 23(4): 354-361.

DEL FIOL F, et al. A febre maculosa no Brasil. Revista Panamericana de Salud Pública, 2010; 27(6): 461–466.

DE SOUZA C, et al. Risk factors associated with the transmission of Brazilian spotted fever in the Piracicaba river basin, State of São Paulo, Brazil. Revista da Sociedade Brasileira de Medicina Tropical, 2015; 48(1): 11–17.

DONALISIO M, et al. Mapping Brazilian spotted fever: Linking etiological agent, vectors, and hosts. Acta Tropica, 2020; 207: 105496.

GAVA M, et al. Aspectos etioepidemiológicos da febre maculosa brasileira: Revisão sistemática. Veterinária e Zootecnia, 2022; 29: 001-020.

HEITMAN K, et al. National Surveillance Data Show Increase in Spotted Fever Rickettsiosis: United States, 2016-2017. American Journal of Public Health, 2019; 109(5): 719-721.

LEITE C, et al. Febre maculosa brasileira no Distrito Federal: relato de infecção sintomática após uso de tratamento precoce. BrazilianJournalof Health Review, 2023; 6(2): 4541-4554.

LUZ H, et al. Epidemiology of capybara-associated Brazilian spotted fever. PLoS Neglected Tropical Diseases, 2019; 13(9): 1-24.

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES. History of Rocky Mountain Labs (RML). | NIH.Disponível em: http://www.niaid.nih.gov/about/rocky-mountain-history. Acessadoem: 08 de setembro de 2024.

PAROLA P, et al. Update on Tick-Borne Rickettsioses around the World: a geographic approach. Clinical Microbiology Reviews, 2013; 26(4): 657-702.

REGAN J, et al. Risk factors for fatal outcome from Rocky Mountain spotted fever in a highly endemic area-Arizona, 2002-2011. Clinical Infectious Diseases, 2015; 60(11): 1659-1666.

RODRIGUES A, et al. The inoculation eschar of Rickettsia parkeri rickettsiosis in Brazil: Importance and cautions. TicksandTick-Borne Diseases, 2023; 14(2): 102127.

RODRIGUES C, et al. Aspectos ecológicos da febre maculosa no Brasil. Saúde & Meio Ambiente, 2020; 9: 143–163.

SALVIANO F, et al. Aspectos clínico-epidemiológicos da febre maculosa brasileira: uma perspectiva contemporânea. BrazilianJournalofImplantologyand Health Sciences, 2023; 5(3): 1052–1080.